What’s more, Kaplan–Meier survival analysis indicated that endometrial cancer patients with higher CLDN4 expression appeared to have a shorter survival probability compared with those patients who expressed lower levels of CLDN4 (Fig. 3m). The gene discussed is CLDN4; the disease is endometrial cancer.